Jefferies Upgrades Varian Medical

Analyst Ryan Rauch cites the company's forecast of 19% worldwide growth in the oncology market

Jefferies & Co. upgraded its recommendation on Varian Medical Systems (VAR ) to buy from hold.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.